001     203086
005     20210129220300.0
024 7 _ |a 10.1007/s00417-014-2652-0
|2 doi
024 7 _ |a 0065-6100
|2 ISSN
024 7 _ |a 0376-0200
|2 ISSN
024 7 _ |a 0721-832X
|2 ISSN
024 7 _ |a 0721-832x
|2 ISSN
024 7 _ |a 1435-702X
|2 ISSN
024 7 _ |a WOS:000347553200004
|2 WOS
024 7 _ |a altmetric:4104577
|2 altmetric
024 7 _ |a pmid:24827634
|2 pmid
037 _ _ |a FZJ-2015-05121
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Rösch, Sarah
|0 P:(DE-HGF)0
|b 0
245 _ _ |a The effects of iodoacetic acid on the mouse retina
260 _ _ |a Berlin
|c 2015
|b Springer
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1438678319_16991
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a Background:To characterize the effects of intravitreal injections of iodoacetic acid (IAA) in comparison to its systemic application as a measure to induce unilateral photoreceptor degeneration.Methods:Seven-week-old C57BL/6 J mice received either intravitreal injections of IAA or systemic treatment (intraperitoneal vs intravenous) and were observed in the following 5 weeks using ERG, OCT, and histology.Results:Systemic treatment with IAA induced high toxic effects and a high mortality in contrast to the intravitreal injection. Intraperitoneal application had no effect on the retina. Intravenous application of 2 × 30 mg/kg BW IAA (time between injections 3.5 h) resulted in an extinction of the ERG and a thinning of the retina, in particular of the outer nuclear layer (ONL) indicating photoreceptor degeneration. Animals receiving intravitreal injections developed cataracts already at low concentrations (up to 100 % at 0.25 mg/kg BW). Higher intravitreal IAA doses led to extinguished ERGs. In histology, a thinning of the entire retina was observed that was most prominent in the inner part of the retina.Conclusions:In contrast to intraperitoneal administration, intravenous application of IAA led to a selective photoreceptor degeneration. After intravitreal injection, dense cataracts were already observed at concentrations lower than those needed to induce changes in the ERG. ERG results must be interpreted carefully. A thinning of all retinal layers rather than a specific outer retinal degeneration was observed upon intravitreal injection. IAA is not a useful model to induce outer retinal degeneration in mice.
536 _ _ |a 553 - Physical Basis of Diseases (POF3-553)
|0 G:(DE-HGF)POF3-553
|c POF3-553
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Johnen, Sandra
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Mazinani, Babac
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Müller, Frank
|0 P:(DE-Juel1)131939
|b 3
|u fzj
700 1 _ |a Pfarrer, Christiane
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Walter, Peter
|0 P:(DE-HGF)0
|b 5
|e Corresponding author
773 _ _ |a 10.1007/s00417-014-2652-0
|g Vol. 253, no. 1, p. 25 - 35
|0 PERI:(DE-600)1459159-5
|n 1
|p 25 - 35
|t Graefe's archive for clinical and experimental ophthalmology
|v 253
|y 2015
|x 1435-702X
856 4 _ |u https://juser.fz-juelich.de/record/203086/files/art_10.1007_s00417-014-2652-0.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/203086/files/art_10.1007_s00417-014-2652-0.gif?subformat=icon
|x icon
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/203086/files/art_10.1007_s00417-014-2652-0.jpg?subformat=icon-1440
|x icon-1440
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/203086/files/art_10.1007_s00417-014-2652-0.jpg?subformat=icon-180
|x icon-180
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/203086/files/art_10.1007_s00417-014-2652-0.jpg?subformat=icon-640
|x icon-640
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/203086/files/art_10.1007_s00417-014-2652-0.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:203086
|p VDB
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)131939
913 1 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-553
|2 G:(DE-HGF)POF3-500
|v Physical Basis of Diseases
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2015
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b GRAEF ARCH CLIN EXP : 2013
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)ICS-4-20110106
|k ICS-4
|l Zelluläre Biophysik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)ICS-4-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-1-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21